Literature DB >> 8098576

[Concentration of ciprofloxacin in bone tissue].

A Meissner1, K Borner.   

Abstract

After the administration of a 200 mg i.v. dose, the concentration of ciprofloxacin in bone and serum of 20 patients with coxarthrosis was determined before implantation of a total hip-joint endoprosthesis. Samples were taken from the cortical bone and cancellous bone either 1 hour, 2 hours, 3 hours, 4 to 5 hours, or 13 to 19 hours after administration. Blood samples for the determination of serum concentration were also taken at these times. The bone samples were extracted three times in phosphoric acid (10 mmol/l) at 4 degrees C for 20 hours, the volume of phosphoric acid being ten times that of the bone sample. The ciprofloxacin concentration was determined by high-performance liquid chromatography and fluorescence detection. The bone concentration was referred to bone volume by assuming a bone density of 1.9 g/l. The mean bone concentrations in cancellous and cortical bone after ciprofloxacin administration were, respectively, 2.16 mg/l and 1.42 mg/l after 1 hour; 0.82 mg/l and 0.56 mg/l after 2 hours; 2.50 mg/l and 1.04 mg/l after 3 hours; 1.16 mg/l and 0.42 mg/1 after 4-5 hours; and 0.27 mg/l and 0.15 mg/l after 13-19 hours. Ciprofloxacin quickly penetrated the bone. The ratio of areas under the curve (AUC) from bone to serum was 2.24 for cancellous and 0.99 for cortical bone. In 16 out of 19 bone samples, the ciprofloxacin concentration measured was higher than the MIC90 for Staphylococcus aureus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098576

Source DB:  PubMed          Journal:  Aktuelle Traumatol        ISSN: 0044-6173


  5 in total

1.  Physiologically Based Population Pharmacokinetic Modeling Approach for Ciprofloxacin in Bone of Patients Undergoing Orthopedic Surgery.

Authors:  Cornelia B Landersdorfer; Martina Kinzig; Rainer Höhl; Peter Kempf; Roger L Nation; Fritz Sörgel
Journal:  ACS Pharmacol Transl Sci       Date:  2020-05-25

Review 2.  Use of quinolones in osteomyelitis and infected orthopaedic prosthesis.

Authors:  D P Lew; F A Waldvogel
Journal:  Drugs       Date:  1999       Impact factor: 9.546

Review 3.  Systemic antibiotic therapy for chronic osteomyelitis in adults.

Authors:  Brad Spellberg; Benjamin A Lipsky
Journal:  Clin Infect Dis       Date:  2011-12-12       Impact factor: 9.079

4.  Antioxidative/oxidative effects and retarding osteoconductivity of ciprofloxacin-loaded porous polyvinyl alcohol/bioactive glass hybrid.

Authors:  Salha Boulila; Hassane Oudadesse; Riadh Badraoui; Bertrand Lefeuvre; Mostafa Mabrouk; Khansa Chaabouni; Amany Mostafa; Fatma Makni-Ayedi; Allal Barroug; Tarek Rebai; Abdelfattah Elfeki; Hafed Elfeki
Journal:  Med Biol Eng Comput       Date:  2016-04-21       Impact factor: 2.602

Review 5.  Quinolones and osteomyelitis: state-of-the-art.

Authors:  D P Lew; F A Waldvogel
Journal:  Drugs       Date:  1995       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.